Okura, Yuu http://orcid.org/0000-0002-6949-8105
Ikawa-Teranishi, Yuri
Mizoroki, Akihiko
Takahashi, Noriyuki http://orcid.org/0000-0001-8954-6998
Tsushima, Takashi
Irie, Machiko
Harfuddin, Zulkarnain
Miura-Okuda, Momoko
Ito, Shunsuke http://orcid.org/0000-0002-6396-4822
Nakamura, Genki
Takesue, Hiroaki http://orcid.org/0000-0001-8585-5494
Ozono, Yui
Nishihara, Masamichi
Yamada, Kenta
Gan, Siok Wan
Hayasaka, Akira
Ishii, Shinya
Wakabayashi, Tetsuya http://orcid.org/0000-0001-9547-1291
Muraoka, Masaru
Nagaya, Nishiki
Hino, Hiroshi
Nemoto, Takayuki
Kuramochi, Taichi
Torizawa, Takuya http://orcid.org/0000-0001-7537-6123
Shimada, Hideaki
Kitazawa, Takehisa
Okazaki, Makoto
Nezu, Junichi http://orcid.org/0000-0003-0476-1264
Sollid, Ludvig M. http://orcid.org/0000-0001-8860-704X
Igawa, Tomoyuki http://orcid.org/0000-0003-0097-8220
Article History
Received: 2 October 2023
Accepted: 29 November 2023
First Online: 22 December 2023
Competing interests
: Y.Okura., Y.I.-T., A.M. are employees of Chugai Pharmaceutical and inventors on patents (WO 2022/059766) related to the antibodies to HLA-DQ, of which all rights have been assigned to the company. Y.Okura., N.T., T.Tsushima., Z.H. are employees of Chugai Pharmaceutical and inventors on patents (WO 2019/069993) related to the antibodies to HLA-DQ, of which all rights have been assigned to the company. Y.Okura., N.T. are employees of Chugai Pharmaceutical and inventors on patents (WO 2018/155692) related to the antibodies to HLA-DQ, of which all rights have been assigned to the company. L.M. Sollid., either privately or via his employer, has been a consultant during the last 3 years for Amagma Therapeutics, Bristol Myers Squibb, Chugai Pharmaceutical, Glaxo Smith Klein, Intrexon Actobiotics, Mozart Therapeutics, Ono Pharmaceutical, SQZ Biotech, and Topas Therapeutics and he is inventor on a patent application describing gluten pHLA-DQ2.5-specific antibodies (WO 2019/158602). The other authors are employees of Chugai Pharmaceutical Co., Ltd., and Chugai Pharmaceutical Co., Ltd. is involved in the research and development of medicines. This study was funded by Chugai Pharmaceutical Co., Ltd.